In summary, our study supports the notion that the presence of NLRP3 accelerates cell loss in optic nerve injury, which establishes a foundation from which to examine the underlying neuroinflammatory mechanisms and a model system in which to test drugs targeting the NLRP3 inflammasome for preservation of vision in optic neuropathy. Here, NLRP3 is linked to Optic neuropathy.